Monoclonal antibody technology has made it possible to produce homogeneous populations of antibodies to discrete determinants on an antigen surface. We have produced monoclonal antibodies to the a-subunit and /3-subunits of the glycoprotein hormones choriogonadotropin, thyrotropin, and lutropin, and developed two-site simultaneous enzyme-linked immunospecific asssays for these hormones. The anti-a-subunit monoclonal antibody was usedas the solid-phase (coated tube) capture antibody for all three hormones; the anti-fl-subunit monocional antibodies were coupled to horseradish peroxidase (EC 1.11.1.7). Cross reactions between the closely related choriogonadotropin and lutropin were apparently greater in this methodthan in RIA,with use of the sameantibodies. Ka of the antibodies did not appear to be as critical to sensitivity of the sandwich assay as it was for RIA. The lower limit of detectionwas 0.2 pg/L after a 2-h incubation with serum sample at room temperature anda 30-mm incubation with enzyme substrateat room temperature after washing away excess enzyme conjugate. Within-assay precision (CV) was very good, <6%.
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The quantitative analysis of biological fluids for the glycoprotein tropic hormones-human choriogonadotropin (hCG), lutropin (luteinizing hormone, LH), follitropin (follicle-stimulating hormones, FSH), and thyrotropin (thyroid-stimulating hormone, TSH)-has been accomplished largely by radioimrnunoassay techniques (1 ). 1 These methods are highly sensitive and can be specific for hCG, FSH, or TSH when anti-$-subunit antisera are used (2, 3) . However, RIAs for LH are affected by cross reaction with the closely related structure of hCG (4) .
The disadvantages of radioactive materials, namely, disposal of waste and short shelf-life of reagents, have led to the development of enzyme-linked immunospecific assay (ELIsA) techniques as an alternative to RIA (5) (6) (7) . Van Weeman and Schuurs described a competitive ELISA for hCG that involved enzyme-labeled antigen (8) . They compared a competitive enzyme immunoassay with the two-site "sandwich" ELISA (9) , in which enzyme-labeled antibody is used, and concluded that the competitive assay was 20-fold more sensitive than the Monoclonal Antibodies, Inc., 2319 Charleston Rd., Mountain View, CA 94043. 1 sandwich assay. The advantage of the sandwich assay is that the enzyme-labeled antibody can be prepared easily and economically; preparation of enzyme-labeled antigen is costly because of the need for purified antigens from human sources.
By use of the hybnidoma technology developed by Milstein and Kohler (10) , monoclonal antibodies to the a-and 3-subunits of the glycoprotein hormones have been prepared (11, 12) . We have incorporated these antibodies into the two-site, sandwich ELISA methodology in developing assays for hCG, TSH, and LH. These assays are similar to the twosite ELISA for a-fetoprotein described by Uotila et al. (13) , in that monoclonal antibodies are used. The anti-a-subunit monoclonal antibody, used as the capture antibody, is coated onto polystyrene tubes. Because of the structurally and immunochemically similar nature of the a-subunits from the glycoprotein hormones (14) , only one solid-phase anti-asubunit monoclonal antibody is required. The anti-f3-subunit monoclonal antibodies, directed against the hormonespecific determinants on the /3-subunit, are coupled to horseradish peroxidase (EC 1.11.1.7) and confer specificity to the test systems. Serum-based samples and enzyme-antibody conjugate are incubated simultaneously in the antibody-coated tubes. We use a single wash step to remove excess enzyme conjugate before assaying for antigen-bound enzyme activity.
Evaluation of the performance of the hCG, LH, and TSH assays indicates that highly sensitive and reproducible twosite, sandwich ELISAS are possible, based on the use of monoclonal antibodies to the a-and /3-subunits.
Here we further characterize these assays and discuss their clinical applications.
Materials and Methods
Monoclonal antibodies. The monoclonal antibodies with specificity for the various glycoprotein hormones were produced by stable clones of cell hybrids, isolated from Balb/c mouse spleen cell NS-1 fusions according to Milstein and Kohler (10) . The clone producing anti-/3-hCG no. 5004 was isolated by Schr#{246}der et al. (11) . Anti-f3-LH no. 0205 was isolated by Federici et al. (12) . Anti-/3-TSH no. 55G2 and antia-TSH no. A57B5 were isolated from the same fusion with TSH immunogen (manuscript in preparation).
We purified the antibodies from ascites fluid harvested from inoculated Balb/c mice by passage through protein A-Sepharose columns (15) . The purified monoclonal antibodies were all found to be monoclonal IgG1 by immunoelectrophoresis and by double diffusion in agarose gels with subclass-specific antisera. Characterization of antibodies by RIA. The purified monoclonal antibodies were evaluated in competitive RIA systems by sequential additions of unlabeled hormone in serum and tracer to antibody, overnight incubation at room temperature, and precipitation with polyethylene glycol 6000, 200 g/L, in place of second antibody (16 for coupling. The enzyme-coupled antibody was chromatographed on a gel-filtration column, ACA-34 (LKB-Produktor AB, Sweden), in phosphate-buffered saline (PBS; per liter, 10 mmol of NaH2PO4 and 9 g of NaCl), pH 7.0, and the eluted fraction containing the conjugate (as determined by enzyme activity) free of uncoupled antibody was pooled and stored at -20 #{176}C.
Coating of tubes with anti-a-subunit antibody. Polystyrene tubes, 12 x 75 mm, were coated with monoclonal antia-TSH no. A57B5 in phosphate-buffered saline at 1-10 mg/L, according to the procedures described by Parsons (19) . Excess coating antibody was removed by several washes with the buffer, and the tubes were stored at 2-8 #{176}C, either wet or after drying by desiccation.
Antigens.
Purified hormones were obtained from Radioassay Systems Labs., Carson, CA 90746. Partly purified hCG was prepared from crude hCG isolated from pregnancy urine by chromatography on Sephadex 0-100 (Pharmacia Fine Chemicals AB, Bromma, Sweden). This hCG preparation was calibrated (by RIA and the described ELISA procedure) against the World Health Organization First International
Reference Preparation (wHo no. 75/537). The antigens were diluted in horse serum (Irvine Scientific, Irvine, CA 92705), 250 mL/L; in PBS; or in hormone-free human male serum (AMS-Biological and Diagnostics
Co., Seguin, TX 78155). Two-site, simultaneous sandwich ELISA protocol. The assay protocols for hCG, TSH, and LH were very similar. The enzyme-conjugate dilution and the incubation times were adjusted to optimize sensitivity and decrease the cross reactivity with the related hormones. Dilute the enzyme conjugate (anti-fl-subunit for hCG, TSH, or LH) 500-to 2000-fold in conjugate buffer: PBS, pH 7.5, containing 1 g of twice-crystallized bovine serum albumin (Sigma Chemical Co.) and 0.4 mL of Tween-20 (Sigma Chemical Co.) per liter. Add 300 fLL of the diluted conjugate to anti-a-subunit-coated tubes followed by 25 or 50 L of serum-based samples. After agitating the tubes, incubate at room temperature for 1-2 h. Remove excess enzyme conjugate by filling and decanting with three 4-mL washes of, per liter, 9g of NaCI and 0.4 mL of Tween-20. This is most easily done by using a Repipet, to dispense wash solution, and a foam tube rack (Scientific Manufacturing Industries, Emeryville, CA 94608) to hold the tubes for decanting. Allow the wash solution to drain from the tubes, then add 500 L of freshly prepared substrate solution (K2HPO4, 10 mmol/L, pH 6.0, containing 0.5 g of o-phenylenediamine and 300 iL of hydrogen peroxide, 300 g/L solution, per liter). Allow the enzymic reaction to proceed at room temperature for 30 mm, then terminate the reaction by adding 0.2 mL of 2.5 molfL H2S04. Read the endpoint absorbance at 490 nm, using a spectrophotometer equipped with a flow-through cuvette (e.g., Gilford Stasar III; Gilford Instrument
Labs. Inc., Oberlin, OH 44074).
Plot the data for reference curves on linear graph paper. A calculator can also be used to store reference curves by using a four-parameter logistic curve-fitting program (20) . Regression analysis of the data points for calculated dose response vs experimental values indicated a correlation coefficient (r) of 0.999 or better.
Results and Discussion

Preparation of Horseradish Peroxidase-Monoclonal Antibody Conjugates
We found the periodate method of Wilson and Nakane (18) to be effective for coupling horseradish peroxidase and monoclonal antibodies. Suitable enzyme/antibody molar ratios were estimated as 1:1 to 2:1 by A405 and A280 measurements. As noted by Wilson and Nakane, lower ratios gave conjugates with low sensitivity and higher ratios could produce high backgrounds.
We also noted that the optimal coupling conditions varied from one monoclonal antibody to another, probably because of the different physical properties of the antibodies as displayed by their varied electrophoretic mobilities in immunoelectrophoresis.
Two-Site Sandwich Assays
Adjustment of enzyme-conjugate dilution.
When hCG and anti-/3-hCG enzyme conjugate were simultaneously incubated in anti-a-subunit-coated tubes, a "sandwich" formed between the solid-phase anti-a-subunit, the hCG molecule, and the anti-fl-enzyme conjugate. The amount of conjugate bound to the tube wall depended on the concentration of hormone, the concentration of enzyme conjugate, and the incubation time in the coated tube. By adjusting the dilution of enzyme conjugate, we adjusted the sensitivity of the assay. Figure 1 shows a titration of enzyme conjugate for two concentrations of hCG and a zero calibrator (50 tL sample volume). By selecting a dilution such that the A490 was 1.0 to 1.5 for an assay having a value of 100 mt. unitsfL (2-h incubation), we obtained a highly sensitive assay having a low background for the zero calibrator and an upper limit of 200 mt. units/L (A490 <3.0) for the assay range. Figure 2 shows the time course of an experiment in which the incubation time is varied from 0.5 to 24 h at room temperature. At the various concentrations of antigen used, the sandwich formation reaction followed pseudo first-order reaction kinetics for about the first 8 h. A representative standard curve for the hCG assay in serum-based media is presented in Figure 3 . The curve appears to be linear between 0 and 10 zg/L, then begins to plateau. Analysis with curvefitting programs indicated that the best fit for the experimental points was achieved by using a four-parameter logistic curve-fitting program as described by Rodbard (21, 22 (22) .
Similar standard curves were obtained for the TSH and LH assays (Figures 4 and 5) .
The sensitivities of these assays were characterized by using 10 replicates of a zero calibrator to calculate the 2 SD range of the negative sample. The lower limit of detection was 0.2 ig/L (1 mt.unitfL) for hCG, 0.2 tg/L (1 milli-int. unit/L) for TSH, and 0.5 tgfL (4 mt.unitsfL) for LH.
Comparison
of the sensitivities of the sandwich ELISA methods with the competitive RIAs for the respective hormones, with use of the monoclonal antibodies in both assays, indicated the highest affinity antibody in competitive RIA, anti-fl-hCG (see Table 1 ), gave a highly sensitive ELJSA, while the lower-affinity (by RIA) anti-fl-TSH gave an ELISA as sensitive as the ELISA for hCG. This result for TSH may be explained by the presence of excess anti-fl-TSH enzyme conjugate, which appears to compensate for lower antibody affmity. Therefore, the specificity of the monoclonal antibody may be more relevant than antibody affinity in determining unitsfL). These results were consistent with the RIA results, in which the TSH assay hada 2.8% cross reactivity with FSH and <1% with hCG and LH. We tested the LH assay system only for cross reactivity with hCG (see Figure 5 ). Cross reaction with hCG was high, approximately 60% at 10 g/L. Further refinements in the system should increase the specificity of the LH assay. To evaluate the precision of the hCG assay, we tested 10 replicates of the standard curve calibrators. The within-assay precision (CV) of the hCG assay (2-h incubation) was similar to that of RIA methods (3) and other enzyme immunoassay methods (23) , being <6% throughout the assay range of in unitsfL ( Figure 6 ).
Evaluation of LH, TSH, and FSH cross reactivity in the
hCG assay system. The cross reactivity of the related glycoprotein hormones in the hCG assay was tested in two ways. (Table 1) . This increase in cross reactivity in the sandwich ELISA may be due to the antibody excess in the assay. For example, in the competitive RIA procedure, we observed that increasing antibody concentrations increased cross reactivity (unpublished data). We also observed that use of lower concentrations of conjugate gave lower cross-reactivity values in the ELISA assays. The second method for evaluating cross reactivity was to determine what effect added FSH and TSH had on hCG recovery in human serum. We did not include LH in this test because it would not be a factor in pregnancy, and its cross reactivity was already established in the LH-supplemented, hCG-negative samples. results. Alternatively, a sequential protocol could be used, incorporating pre-incubation with sample and a wash step to remove excess antigen before incubation with enzyme conjugate. The sequential protocol would obviate the question of antigen excess causing falsely low or negative results.
The LH assay has a potential application as an aid for infertility testing, the pre-ovulatory increase in serum LH being a good indicator of the beginning of the ovulatory phase of the menstrual cycle (27) . The two-site simultaneous ELISA with monoclonal antibodies has the requisite sensitivity for this determination.
The TSH assay demonstrated the potential usefulness of this sensitive test system in measuring serum concentrations of TSH; however, several concerns reduce the clinical usefulness of this test system. Concentrations of hCG as high as encountered during pregnancy interfered with this test by competing for anti-a-subunit solid-phase antibody, and cross reactivity with FSH was 6.9%, too great for the highly sensitive assay required for TSH quantification. We are currently exploring several modifications of the test system to overcome these problems.
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